Jonathan E. Lim, M.D.

Jonathan E. Lim, M.D.

Chairman, Chief Executive Officer, and Co-FounderatErasca· In proxies 2022–2025

Pay in FY2025+10% from the year before · Erasca stock +48.2% the same year

Jonathan E. Lim, M.D. was paid $4.3M in FY2025 (Dec), up 10%. Erasca stock rose 48.2% that year.

Pay$100 in the stock at the end of FY21 → $24
Pay is from the Summary Compensation Table of each Erasca proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ErascaPublic company · 4 yr
    • Chairman, Chief Executive Officer, and Co-Founder2022 – Present · 4 yrStock in role +6%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?